Amgen Inc insider trading
AMGNfinancial statementsForm 4 filings on EDGAR227 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Amgen Inc bought $0 of stock in the open market, and 3 sold $4M. Officers and directors accounted for $0 of purchases and $4M of sales. The last reported transaction was an option exercise by Khosla Rachna on August 13, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 13, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $4MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
227 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Khosla Rachna | SVP, Business Development | option exercise | 1,252 | $162.60 | $204K | 7,656 | Aug 13, 2026 |
| Aug 13, 2026 | Khosla Rachna | SVP, Business Development | open-market sale | 1,252 | $416.43 | $521K | 6,404 | Aug 13, 2026 |
| Aug 11, 2026 | Khosla Rachna | SVP, Business Development | open-market sale | 2,000 | $412.57 | $825K | 6,404 | Aug 13, 2026 |
| Aug 7, 2026 | Busch Matthew C. | VP, Finance & CAO | award | 730 | $0.00 | — | 5,080 | Aug 12, 2026 |
| Aug 7, 2026 | Ishrak Omar | Director | award | 85 | $0.00 | — | 7,486 | Aug 10, 2026 |
| Aug 7, 2026 | Holley Charles M | Director | award | 103 | $0.00 | — | 12,990 | Aug 10, 2026 |
| Aug 7, 2026 | Drake Michael V | Director | award | 64 | $0.00 | — | 5,876 | Aug 10, 2026 |
| Aug 6, 2026 | Miller Derek | SVP, Human Resources | option exercise | 2,069 | $162.60 | $336K | 14,531 | Aug 7, 2026 |
| Aug 6, 2026 | Miller Derek | SVP, Human Resources | open-market sale | 2,069 | $402.54 | $833K | 12,462 | Aug 7, 2026 |
| Aug 6, 2026 | Miller Derek | SVP, Human Resources | option exercise | 1,821 | $177.46 | $323K | 14,283 | Aug 7, 2026 |
| Aug 6, 2026 | Miller Derek | SVP, Human Resources | open-market sale | 1,821 | $402.54 | $733K | 12,462 | Aug 7, 2026 |
| Aug 6, 2026 | Grygiel Nancy A. | SVP & CCO | option exercise | 1,970 | $177.46 | $350K | 9,310 | Aug 7, 2026 |
| Aug 6, 2026 | Grygiel Nancy A. | SVP & CCO | open-market sale | 1,970 | $402.16 | $792K | 7,340 | Aug 7, 2026 |
| Aug 6, 2026 | Grygiel Nancy A. | SVP & CCO | option exercise | 1,000 | $177.31 | $177K | 8,340 | Aug 7, 2026 |
| Aug 6, 2026 | Grygiel Nancy A. | SVP & CCO | open-market sale | 1,000 | $402.16 | $402K | 7,340 | Aug 7, 2026 |
| May 19, 2026 | Miles Amy E | Director | award | 665 | $0.00 | — | 5,640 | May 21, 2026 |
| May 19, 2026 | Kullman Ellen Jamison | Director | award | 665 | $0.00 | — | 14,536 | May 21, 2026 |
| May 19, 2026 | Klotman Mary E. | Director | award | 665 | $0.00 | — | 2,211 | May 21, 2026 |
| May 19, 2026 | Jacks Tyler | Director | award | 665 | $0.00 | — | 18,284 | May 21, 2026 |
| May 19, 2026 | Ishrak Omar | Director | award | 665 | $0.00 | — | 7,359 | May 21, 2026 |
| May 19, 2026 | Holley Charles M | Director | award | 665 | $0.00 | — | 12,799 | May 21, 2026 |
| May 19, 2026 | Garland Greg C. | Director | award | 665 | $0.00 | — | 13,848 | May 21, 2026 |
| May 19, 2026 | Eckert Robert | Director | award | 665 | $0.00 | — | 26,251 | May 21, 2026 |
| May 19, 2026 | Druker Brian | Director | award | 665 | $0.00 | — | 8,391 | May 21, 2026 |
| May 19, 2026 | Drake Michael V | Director | award | 665 | $0.00 | — | 5,774 | May 21, 2026 |
| May 19, 2026 | Austin Wanda M | Director | award | 665 | $0.00 | — | 8,018 | May 21, 2026 |
| May 7, 2026 | Busch Matthew C. | VP, Finance & CAO | tax withholding | 41 | $331.11 | $14K | 4,344 | May 11, 2026 |
| May 7, 2026 | Santos Esteban | EVP, Operations | tax withholding | 522 | $331.11 | $173K | 82,847 | May 11, 2026 |
| May 7, 2026 | Reese David M | EVP & Chief Technology Officer | tax withholding | 556 | $331.11 | $184K | 42,256 | May 11, 2026 |
| May 7, 2026 | Miller Derek | SVP, Human Resources | tax withholding | 151 | $331.11 | $50K | 12,444 | May 11, 2026 |
| May 7, 2026 | Khosla Rachna | SVP, Business Development | tax withholding | 93 | $331.11 | $31K | 8,394 | May 11, 2026 |
| May 7, 2026 | Grygiel Nancy A. | SVP & CCO | tax withholding | 88 | $331.11 | $29K | 7,330 | May 11, 2026 |
| May 7, 2026 | Griffith Peter H. | EVP & CFO | tax withholding | 556 | $331.11 | $184K | 50,150 | May 11, 2026 |
| May 7, 2026 | Graham Jonathan P | EVP & Gen. Counsel & Sec. | tax withholding | 499 | $331.11 | $165K | 39,712 | May 11, 2026 |
| May 7, 2026 | Gordon Murdo | EVP, Global Commercial Ops | tax withholding | 615 | $331.11 | $204K | 51,222 | May 11, 2026 |
| May 7, 2026 | Bradway Robert A | Chairman, CEO and President, Director | tax withholding | 2,079 | $331.11 | $688K | 505,160 | May 11, 2026 |
| May 7, 2026 | Bradner James E. | EVP, Research and Development | tax withholding | 446 | $331.11 | $148K | 30,016 | May 11, 2026 |
| May 6, 2026 | Bradner James E. | EVP, Research and Development | tax withholding | 407 | $329.59 | $134K | 30,462 | May 7, 2026 |
| May 6, 2026 | Bradway Robert A | Chairman, CEO and President, Director | tax withholding | 1,702 | $329.59 | $561K | 507,239 | May 7, 2026 |
| May 6, 2026 | Busch Matthew C. | VP, Finance & CAO | tax withholding | 50 | $329.59 | $16K | 4,385 | May 7, 2026 |
| May 6, 2026 | Gordon Murdo | EVP, Global Commercial Ops | tax withholding | 502 | $329.59 | $165K | 51,837 | May 7, 2026 |
| May 6, 2026 | Graham Jonathan P | EVP & Gen. Counsel & Sec. | tax withholding | 408 | $329.59 | $134K | 40,211 | May 7, 2026 |
| May 6, 2026 | Griffith Peter H. | EVP & CFO | tax withholding | 502 | $329.59 | $165K | 50,706 | May 7, 2026 |
| May 6, 2026 | Grygiel Nancy A. | SVP & CCO | tax withholding | 76 | $329.59 | $25K | 7,418 | May 7, 2026 |
| May 6, 2026 | Khosla Rachna | SVP, Business Development | tax withholding | 79 | $329.59 | $26K | 8,487 | May 7, 2026 |
| May 6, 2026 | Miller Derek | SVP, Human Resources | tax withholding | 123 | $329.59 | $41K | 12,595 | May 7, 2026 |
| May 6, 2026 | Reese David M | EVP & Chief Technology Officer | tax withholding | 454 | $329.59 | $150K | 42,812 | May 7, 2026 |
| May 6, 2026 | Santos Esteban | EVP, Operations | tax withholding | 427 | $329.59 | $141K | 83,369 | May 7, 2026 |
| May 5, 2026 | Bradner James E. | EVP, Research and Development | award | 3,337 | $0.00 | — | 30,869 | May 7, 2026 |
| May 5, 2026 | Bradway Robert A | Chairman, CEO and President, Director | award | 12,136 | $0.00 | — | 508,941 | May 7, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations | May 7, 2026 | tax withholding | 82,847 | — | $21M (2) | 0 of 2 |
| Grygiel Nancy A. | SVP & CCO | Aug 6, 2026 | option exercise | 9,310 | — | $3M (5) | 0 of 5 |
| Gordon Murdo | EVP, Global Commercial Ops | May 7, 2026 | tax withholding | 51,222 | — | $2M (1) | 0 of 1 |
| Khosla Rachna | SVP, Business Development | Aug 13, 2026 | option exercise | 7,656 | — | $2M (3) | 0 of 3 |
| Miller Derek | SVP, Human Resources | Aug 6, 2026 | option exercise | 14,531 | — | $2M (2) | 0 of 2 |
| Busch Matthew C. | VP, Finance & CAO | Aug 7, 2026 | award | 5,080 | — | $376K (1) | 0 of 1 |
| Reese David M | EVP & Chief Technology Officer | May 7, 2026 | tax withholding | 42,256 | — | — | — |
| Bradway Robert A | Chairman, CEO and President, Director | May 7, 2026 | tax withholding | 505,160 | — | — | — |
| Graham Jonathan P | EVP & Gen. Counsel & Sec. | May 7, 2026 | tax withholding | 39,712 | — | — | — |
| Griffith Peter H. | EVP & CFO | May 7, 2026 | tax withholding | 50,150 | — | — | — |
| Ishrak Omar | Director | Aug 7, 2026 | award | 7,486 | — | — | — |
| Holley Charles M | Director | Aug 7, 2026 | award | 12,990 | — | — | — |
| Drake Michael V | Director | Aug 7, 2026 | award | 5,876 | — | — | — |
| Bradner James E. | EVP, Research and Development | May 7, 2026 | tax withholding | 30,016 | — | — | — |
| Miles Amy E | Director | May 19, 2026 | award | 5,640 | — | — | — |
| Kullman Ellen Jamison | Director | May 19, 2026 | award | 14,536 | — | — | — |
| Klotman Mary E. | Director | May 19, 2026 | award | 2,211 | — | — | — |
| Jacks Tyler | Director | May 19, 2026 | award | 18,284 | — | — | — |
| Garland Greg C. | Director | May 19, 2026 | award | 13,848 | — | — | — |
| Eckert Robert | Director | May 19, 2026 | award | 26,251 | — | — | — |
| Druker Brian | Director | May 19, 2026 | award | 8,391 | — | — | — |
| Austin Wanda M | Director | May 19, 2026 | award | 8,018 | — | — | — |
Questions
Are Amgen Inc insiders buying or selling?
Over the twelve months to November 1, 2026, 6 insiders at Amgen Inc sold $29M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $29M. Only open-market purchases and sales are counted.
Who sold the most Amgen Inc stock in the last year?
Santos Esteban (EVP, Operations) sold $21M in 2 open-market sales over the twelve months to November 1, 2026.
Do Amgen Inc executives sell under 10b5-1 plans?
0 of the 14 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Amgen Inc
- Amgen Inc financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.